搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
4 天
on MSN
New cancer therapy strategy targets GLUT3 in regulatory T cells to supercharge anti-tumor ...
Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...
Cure Today
8 天
FDA Approves CAR-T Cell Therapy for Relapsed or Refractory B-Cell ALL
The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...
The EMBO Journal
12 天
Making contact away from home: a bacterial secreted effector mediates inter-organelle ...
Inter-organelle communication via the formation of membrane contact sites (MCS) is essential for cell homeostasis. Bacterial pathogens residing in membrane bound vacuoles have exploited this ...
The American Journal of Managed Care
10 天
KIR2DS2+ NK Cells Show Potential in HCC and Leukemia Treatment
These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target ...
The American Journal of Managed Care
8 天
FDA Approves Obe-Cel for R/R B-Cell Acute Lymphoblastic Leukemia
Safety concerns include low levels of grade 3 cytokine release syndrome and immune effector cell-associated neurotoxicity ...
Medpage Today on MSN
7 天
CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record
LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...
Taiwan News
8 天
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted ...
Off-the-shelf Product Candidate Incorporates Novel Sword & Shield Technology Designed to Promote Functional Persistence without Conditioning Chemotherapy FT836 Preclinical Data Shows Robust ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈